Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02572570 · ClinicalTrials.gov registry record · NA

Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth

A NA study, sponsored by University of North Carolina, Chapel Hill.

Terminated
Registry status
NA
Development phase
27
Enrollment target

NCT02572570 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02572570, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.

TERMINATED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

Polymerization shrinkage remains one of the primary disadvantages of composite resin restorative materials (tooth-colored fillings). To minimize the effects of polymerization shrinkage in the restorative treatment, the 3M ESPE company has developed a composite resin called Filtek Bulk Fill Posterior Restorative. Its decreased polymerization shrinkage and properties allow the material to be inserted in one single increment, expediting treatment. This clinical trial is designed to evaluate the performance of the new bulk fill composite resin in Class II (two-surface posterior) fillings.

Interventions

  • DEVICE Filtek Bulk Fill Posterior
  • DEVICE Filtek Supreme Ultra

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2015-12
Est. Completion 2019-12-05
Phase NA

What the Registry Record Tells You About NCT02572570

The ClinicalTrials.gov registry entry for NCT02572570 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Filtek Bulk Fill Posterior is the first listed.

NCT02572570 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02572570 about?

NCT02572570 is a clinical study titled "Clinical Investigation of a New Bulk Fill Composite Resin in the Restoration of Posterior Teeth". Polymerization shrinkage remains one of the primary disadvantages of composite resin restorative materials (tooth-colored fillings). To minimize the effects of polymerization shrinkage in the restorative treatment, the 3M ESPE company has developed a composite resin called Filtek Bulk Fill Posterior...

What is the current status of trial NCT02572570?

This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2015-12. Estimated completion is 2019-12-05.

What interventions are being tested in trial NCT02572570?

The interventions under investigation include: Filtek Bulk Fill Posterior (DEVICE), Filtek Supreme Ultra (DEVICE).

Who is sponsoring clinical trial NCT02572570?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.